Donghua Zhang

7PUBLICATIONS
2CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 19, 2024
A differential diagnosis method for systemic CAEBV and the prospect of EBV-related immune cell markers via flow cytometry.

Jie Jin, Xia Mao, Donghua Zhang

|Jan 03, 2023
Cladribine- and decitabine-containing conditioning regimen has a low post-transplant relapse rate in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.

Xiwen Tong, Mengyuan Li, Jie Jin

|Jul 15, 2022
DNA methyltransferase-1 in acute myeloid leukaemia: beyond the maintenance of DNA methylation.

Mengyuan Li, Donghua Zhang

|Jun 01, 2021
A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia.

Yi Li, Xiwen Tong, Lifang Huang

|Apr 10, 2021
Reinduction chemotherapy regimen involved decitabine and cladribine improves the prognosis of patients with relapsed or refractory acute myeloid leukemia: A preliminary study.

Yan Hui, Yi Li, Xiwen Tong

|Mar 10, 2021
The predictive value of regulatory T cells on glucocorticoid sensitivity in patients with immune thrombocytopenia: a multicentre, prospective clinical study.

Li Li, Yanhong Zhao, Xiwen Tong

Pageof 2

Frequent Collaborators

1 joint publications

Li Li

1 joint publications

Xia Mao